Update on outcome assessment in rheumatic disorders

被引：14

作者：

Molenaar, E

van der Heijde, D

Boers, M

机构：

[1] Vrije Univ Amsterdam, Univ Hosp, Dept Rheumatol, NL-1007 MD Amsterdam, Netherlands

[2] Univ Hosp Maastricht, Dept Rheumatol, Maastricht, Netherlands

[3] Vrije Univ Amsterdam, Univ Hosp, Dept Clin Epidemiol, Amsterdam, Netherlands

来源：

CURRENT OPINION IN RHEUMATOLOGY | 2000年 / 12卷 / 02期

关键词：

D O I：

10.1097/00002281-200003000-00002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Outcome assessment in rheumatic disorders is getting more and more attention. A series of Outcome Measures in Rheumatology (OMERACT) conferences has provided a good impulse for further research in the field. In this chapter we will review the results of the last OMERACT 4 conference in detail. This conference was focused on longitudinal/observational studies, rheumatoid arthritis (response criteria and imaging), and core sets for ankylosing spondylitis and systemic lupus erythematosus. Moreover, an overview of recent literature on measures of disease activity, quality of life measures, and imaging is presented, for the various rheumatic disorders, several new instruments and/or further validation steps are described. Curr Opin Rheumatol 2000, 12:91-98 (C) 2000 Lippincott Williams & Wilkins, Inc.

引用

页码：91 / 98

页数：8

共 88 条

[31]

Husted JA, 1998, J RHEUMATOL, V25, P2146

[32] The SF-36 Arthritis-Specific Health Index (ASHI) II. Tests of validity in four clinical trials [J].